Resistance to irinotecan (CPT-11) activates epidermal growth factor receptor/nuclear factor kappa B and increases cellular metastasis and autophagy in LoVo colon cancer cells

被引：28

作者：

Chen, Ming-Cheng ^{[1
,2
]}

Lee, Nien-Hung ^{[1
]}

Ho, Tsung-Jung ^{[3
]}

Hsu, Hsi-Hsien ^{[4
,5
]}

Kuo, Chia-Hua ^{[6
]}

Kuo, Wei-Wen ^{[7
]}

Lin, Yueh-Min ^{[8
,9
]}

Tsai, Fuu-Jen ^{[10
]}

Tsai, Chang-Hai ^{[11
]}

Huang, Chih-Yang ^{[1
,10
,12
]}

机构：

[1] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan

[2] Taichung Vet Gen Hosp, Puli Branch, Nantou, Taiwan

[3] China Med Univ, Beigang Hosp, Chinese Med Dept, Yunlin, Taiwan

[4] Mackay Mem Hosp, Div Colorectal Surg, Taipei, Taiwan

[5] Nursing & Management Coll, Mackay Jr Coll Med, Taipei, Taiwan

[6] Univ Taipei, Dept Sports Sci, Taipei, Taiwan

[7] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan

[8] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan

[9] Jen Teh Jr Coll Med, Dept Med Technol, Miaoli, Taiwan

[10] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan

[11] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan

[12] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan

来源：

CANCER LETTERS | 2014年 / 349卷 / 01期

关键词：

Chemoresistance; CPT-11; NF-kappa B; Metastasis; Autophagy; COLORECTAL-CANCER; INDUCIBLE CHEMORESISTANCE; ANTICANCER DRUGS; GEFITINIB IRESSA; INHIBITION; CHEMOTHERAPY; MECHANISMS; THERAPY; DEATH; 5-FLUOROURACIL;

D O I：

10.1016/j.canlet.2014.03.023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Chemotherapy is usually applied to treat colon cancer but leads to chemoresistance, and increased metastasis and invasion. The main focus of this study is to observe effects of resistance to irinotecan (CPT-11) on metastasis, invasion and autophagy in CPT-11 resistant (CPT-11-R) LoVo colon cancer cells. CPT-11, a topoisomerase I inhibitor and a first-line chemotherapeutic drug, is used to treat colon cancer. CPT-11-R cells were constructed in a step-wise fashion with increasing CPT-11 doses. The CPT-11-R strain had a significantly lower expression of Wnt/beta-catenin pathway, but induced an EGFR/IKK alpha/beta/NF-kappa B pathway with elevated cell cycle, metastasis and basal autophagy. C) 2014 Elsevier Ireland Ltd. All rights reserved.

引用

页码：51 / 60

页数：10

共 50 条

[1] Inhibition of NF-B and metastasis in irinotecan (CPT-11)-resistant LoVo colon cancer cells by thymoquinone via JNK and p38
Chen, Ming-Cheng
Lee, Nien-Hung
Hsu, Hsi-Hsien
Ho, Tsung-Jung
Tu, Chuan-Chou
Chen, Ray-Jade
Lin, Yueh-Min
Viswanadha, Vijaya Padma
Kuo, Wei-Wen
Huang, Chih-Yang
ENVIRONMENTAL TOXICOLOGY, 2017, 32 (02) : 669 - 678
[2] The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan
Braun, AH
Stark, K
Dirsch, O
Hilger, RA
Seeber, S
Vanhoefer, U
ANTI-CANCER DRUGS, 2005, 16 (10) : 1099 - 1108
[3] Epidermal growth factor activates nuclear factor-κB in human proximal tubule cells
Häussler, U
von Wichert, G
Schmid, RM
Keller, F
Schneider, G
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 289 (04) : F808 - F815
[4] Targeted delivery of irinotecan to colon cancer cells using epidermal growth factor receptor-conjugated liposomes
Liu, Yongwei
Li, Xinghui
Pen, Renqun
Zuo, Wei
Chen, Ya
Sun, Xiuying
Gou, Juhua
Guo, Qianwen
Wen, Maoling
Li, Wuqi
Yu, Shuangjiang
Liu, Hao
Huang, Min
BIOMEDICAL ENGINEERING ONLINE, 2022, 21 (01)
[5] Targeted delivery of irinotecan to colon cancer cells using epidermal growth factor receptor-conjugated liposomes
Yongwei Liu
Xinghui Li
Renqun Pen
Wei Zuo
Ya Chen
Xiuying Sun
Juhua Gou
Qianwen Guo
Maoling Wen
Wuqi Li
Shuangjiang Yu
Hao Liu
Min Huang
BioMedical Engineering OnLine, 21
[6] Angiocidin inhibits breast cancer proliferation through activation of epidermal growth factor receptor and nuclear factor kappa (NF-κB)
Godek, Jessica
Sargiannidou, Irene
Patel, Sneha
Hurd, Lauren
Rothman, Vicki L.
Tuszynski, George P.
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2011, 90 (03) : 244 - 251
[7] Expression of the activated/phosphorylated epidermal growth factor receptor (EGFR) and downstream effectors, as markers predicting the response to cetuximab (C225) alone or in combination with irinotecan (CPT-11) in EGFR-positive metastatic coloerectal cancer (MCRC) refractory to CPT-11
Personeni, Nicola
Hendlisz, Alain
Galdon, Maria Gomez
Gallez, Julien
Larsimont, Denis
Van Laethem, Jean Luc
Nagy, Nathalie
Barette, Martine
Cardoso, Fatima
Bleiberg, Harry
ANNALS OF ONCOLOGY, 2004, 15 : 71 - 71
[8] Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib
Zhang, Xiang
Nagahara, Hisashi
Mimori, Koshi
Inoue, Hiroshi
Sawada, Tetsuji
Ohira, Masaichi
Hirakawa, Kosei
Mori, Masaki
ONCOLOGY REPORTS, 2008, 19 (06) : 1541 - 1544
[9] Acne-like rash predicts response in patients treated with Cetuximab (IMC-C225) plus Irinotecan (CPT-11) in CPT-11-refractory colorectal cancer (CRC) that expresses epidermal growth factor receptor (EGFR).
Saltz, L
Rubin, MS
Hochster, HS
Tchekmeydian, NS
Waksal, HW
Needle, MN
Lobuglio, AF
CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3766S - 3766S
[10] Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation
Dhawan, P.
Ahmad, R.
Chaturvedi, R.
Smith, J. J.
Midha, R.
Mittal, M. K.
Krishnan, M.
Chen, X.
Eschrich, S.
Yeatman, T. J.
Harris, R. C.
Washington, M. K.
Wilson, K. T.
Beauchamp, R. D.
Singh, A. B.
ONCOGENE, 2011, 30 (29) : 3234 - 3247

← 1 2 3 4 5 →